Don't Forget To
Rate This Article

Accelerate Diagnostics Inc. (AXDX:NASDAQ) -- Placeholder sh
Trending Company

(8/15/22)

aaa

ddd

Expert Expects Life Science Co. To Do Exceptionally Well
Source: PennyQueen (08/15/2022)

Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.

MRI Device Maker's Earnings Come In at High End of Forecasts
Source: Streetwise Reports (08/03/2022)

IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins, and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).

Biomedical Firms Merger Makes Programming Cells Easier
Source: Streetwise Reports (07/26/2022)

Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million.

The Utah-based diagnostics firm has multiple shots on goal with this specific molecular test and with its convenient, fast testing platform, both in development, noted an H.C. Wainwright & Co. report.

FDA Approves New Skin Resurfacing Device
Source: Streetwise Reports (05/26/2022)

Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures.